Feedback
Galectin-3, Serum
2007138
Ordering Recommendation

Use for prognostication in heart failure. Test complements prognostic value of N-terminal pro-brain natriuretic peptide (NT-proBNP).

Mnemonic
GALECTIN
Methodology
Quantitative Enzyme Immunoassay
Performed
Wed
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Plain Red 
Specimen Preparation
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transport 1 mL serum. (Min: 0.2 mL) 
Storage/Transport Temperature
Frozen 
Unacceptable Conditions
Plasma. Visibly hemolyzed specimens 
Remarks
 
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 4 months (Avoid repeated freeze/thaw cycles) 
Reference Interval
Effective November 16, 2015
Less than or equal to 22.1 ng/mL
Interpretive Data
An elevated concentration of galectin-3 is associated with increased cardiovascular risk and adverse outcome in patients with heart failure. Medical management should rely on clinical findings.

Low risk: less than or equal to 17.8 ng/mL
Intermediate risk: 17.9-25.9 ng/mL;
Higher risk: Greater than 25.9 ng/mL.

Note
Hotline History
View Hotline History
Components
Component Test Code*Component Chart NameLOINC
2007139Galectin-3, Serum83099-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Gal-3
  • Galectin